Company Filing History:
Years Active: 2012-2019
Title: Jiten Ranchhodbhai Patel: Innovator in Anti-Inflammatory Compounds
Introduction
Jiten Ranchhodbhai Patel, based in Baroda, India, is a prominent inventor known for his contributions in the field of pharmaceutical innovations. With a total of four patents to his name, Patel has made significant strides in developing compounds that target inflammatory conditions.
Latest Patents
His latest patents include groundbreaking work on crystalline forms of a novel glucocorticoid compound. One of his notable patents is titled “Crystalline forms of S-[4-(3-fluoro-3-methylbutyryloxy)but-2-ynyl] 6-α,9-α-difluoro-17-α-(furan-2-yl)carbonyloxy-11-β-hydroxy-16-α-methyl-3-oxoandrosta-1,4-diene-17-β-carbothioate.” This invention focuses on anti-inflammatory and anti-allergic properties of the compound. Additionally, he has worked on methods of treatment of inflammatory conditions utilizing the same compound, which highlights its potential in therapeutic applications.
Career Highlights
Jiten Patel is currently employed by Sun Pharma Advanced Research Company Limited, where he continues his innovative work in the pharmaceutical sector. His career is marked by a commitment to enhancing the efficacy and safety of important therapeutic compounds, particularly those used for treating inflammatory diseases.
Collaborations
In his professional journey, Patel has collaborated with a skilled team, including notable coworkers Gopalkumar Chimanlal Patel and Gaurav Sanjivkumar Sheth. Their collective expertise and cooperation in research have enabled the advancement of significant pharmaceutical innovations.
Conclusion
Jiten Ranchhodbhai Patel's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents, focusing on critical anti-inflammatory compounds, demonstrate the importance of ongoing research and development in creating effective treatments. As he continues his work at Sun Pharma, his contributions are expected to have a lasting impact on future medical advancements.